Free Trial

Oncotelic Therapeutics (OTLC) News Today

Oncotelic Therapeutics logo
$0.04 +0.00 (+1.60%)
As of 05/5/2026 03:53 PM Eastern

OTLC Latest News

Oncotelic Therapeutics Delays Annual 10-K Filing
Oncotelic Therapeutics CEO Presents at LD Micro
Oncotelic to Present at the LD Micro Main Event XIX
Get Oncotelic Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for OTLC and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OTLC Media Mentions By Week

OTLC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OTLC
News Sentiment

0.00

0.56

Average
Medical
News Sentiment

OTLC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OTLC Articles
This Week

1

1

OTLC Articles
Average Week

Get the Latest News and Ratings for OTLC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Oncotelic Therapeutics and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (OTCMKTS:OTLC) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners